Approval · Notice of Compliance 5013 · 1995
BREVIBLOC: Notice of Compliance 5013
Issued January 24, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5013
- Date
- January 24, 1995
- Company
- Ohmeda Pharmaceutical Products, Division Of Boc Canada LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in packaging
- Therapeutic class
- Beta-adrenergic receptor blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BREVIBLOC | Not yet assigned | — |
Medicinal ingredients
- ESMOLOL HYDROCHLORIDE 10 MG per ML